A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass

Trial Profile

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Delirium; Postoperative complications
  • Focus Therapeutic Use
  • Sponsors Hospira
  • Most Recent Events

    • 23 Jul 2015 Status changed from discontinued to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 29 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top